Supernus Pharmaceuticals Sets October 29 Call for Third Quarter 2026 Results

Supernus Pharmaceuticals (SUPN) said it will report third-quarter 2026 financial and business results after the market closes on October 29, 2026.

President and CEO Jack Khattar and Senior Vice President and CFO Tim Dec will host a conference call and webcast at 4:30 p.m. ET that day.

• Results release date: Thursday, October 29, 2026, after market close.
• Conference call and webcast: 4:30 p.m. ET on October 29, 2026.
• Live webcast: Supernus investor relations website.
• A replay will be available on the company’s investor relations website for 60 days following the call.

$SUPN Hedge Fund Activity

We have seen 153 institutional investors add shares of $SUPN stock to their portfolio, and 147 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• POINT72 ASSET MANAGEMENT, L.P. removed 1,318,555 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $61,325,993
• TWO SIGMA INVESTMENTS, LP added 913,150 shares (+336.7%) to their portfolio in Q2 2026, for an estimated $42,470,606
• ARMISTICE CAPITAL, LLC added 750,854 shares (+39.6%) to their portfolio in Q2 2026, for an estimated $34,922,219
• SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 703,552 shares (+inf%) to their portfolio in Q2 2026, for an estimated $32,722,203
• BLACKROCK, INC. added 552,792 shares (+6.3%) to their portfolio in Q2 2026, for an estimated $25,710,355
• MILLENNIUM MANAGEMENT LLC added 537,239 shares (+16.2%) to their portfolio in Q2 2026, for an estimated $24,986,985
• SOLEUS CAPITAL MANAGEMENT, L.P. added 520,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $24,185,200

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.